
Anesthesiology & Pain Management
Latest News
Latest Videos

CE Content
More News

Marlis Rezende, DVM, PhD, MSc, DACVAA, discusses the common conditions she sees in practice that best utilize TIVA for pain management.

Mike Barletta, DVM, MS, PhD, DACVAA; Tasha McNerney, CVT, CVPP, VTS (Anesthesia & Analgesia); and Kristen Ward, BSN-RN, RVT, VTS, shared their approach at Fetch Nashville 2025

These articles focus on creating a plan for managing canine osteoarthritis, helpful tips for pet owners to implement at home, and a study that aims to better understand how IVDD affects a patient over the long term.

Maintaining a lean body condition is the only proven method of delaying and reducing the severity of osteoarthritis, says Kristin Kirkby Shaw, DVM, PhD, MS, DACVS-SA, DACVSMR, in this interview.

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

David Dycus, DVM, MS, CCRP, DACVS-SA, outlines key tips to safeguard a pet’s joint health

Supplement for managing canine OA is launched in the US market
The nutraceutical 4CYTE Epiitalis Forte Dog was previously only available abroad and is now distributed domestically by epiq Animal Health and Interpath Global.

I’m a dachshund. And I’m proud of it.

Current levels of pain management administration by dairy producers and veterinarians in Europe and North America are low.

Lydia Love, DVM, DACVAA, discusses the rationale, technological advances, and training imperatives that underpin the updated 2025 ACVAA guidelines

Felixvet has introduced a carprofen therapy with the same therapeutic benefits as Rimadyl

Gianluca Bini, DVM, MRCVS, DACVAA, describes how sedation compares to general anesthesia, including risks and benefits, in a dvm360 interview.

Jb Minter, DVM, MS, DACZM, discusses potential complications that can arise when amphibians are under anesthesia

Many therapies exist for osteoarthritis, but the best approach is multimodal and patient-specific.

Approved by the FDA in January 2024, EquiCoxib is a noninvasive, liquid formulation.















